Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Steve SHEN
Steve SHEN
Positions:

CEO

Company:

Convalife (Shanghai) Co., Ltd.

Dr. Shen Xiaokun, CEO of Convalife Pharmaceutical Co., Ltd., graduated from Wuhan University with degrees in clinical medicine and Bioscience, and obtained Ph.D degree in pharmacology from Shanghai Institute of Materia Medica, CAS. Dr. Shen has been engaged in the research and development of new drugs for small molecules and antibodies in Hengrui, Novartis and other well-known enterprises. Dr. Shen has more than 10 years of experience in the research and development of new drugs. He has led and participated ~10 projects in the clinical development of new drugs in the fields of anti-tumor, immunity, dermatology and other diseases. He has also helped several drugs to be successfully NDA in China, including first in class IL-17 antibody, Cosentyx, etc. Convalife originated from Latin “valere”, meaning “value and strong”Convalife is an innovative, research-based, clinical stage biopharmaceutical company focused on bringing innovative therapies for cancer, autoimmune and infectious diseases to patients in China and around the world. Convalife develops new therapies with the potential of 'first in class' and 'best in class', and has strong new drug R & D and clinical development capabilities. Convalife obtained investment of famous listed companies such as Wuxibiologics (HK. 02269), Menovo Pharmaceutical (603538) etc.